October 29, 2026
HHC Vaping and Psychosis - Insights from an Inpatient Study
Share:
HHC Vaping and Psychosis
Insights from an Inpatient Study
Dr. Sarah Lanigan is a registrar in University Hospital Galway, with particular interest in psychiatric research, specifically the effects of emerging psychoactive substances.
Recent work focuses on hexahydrocannabinol (HHC) and psychosis.
Date: Monday November 9
Time: 2.30pm
Book: https://www.wrdatf.ie/training-awareness-week.php
For details on all our 2026 Regional Awareness Week Events, see https://www.wrdatf.ie/training-awareness-week.php
